This study is designed to test a medicine called tildrakizumab, given under the skin, for people with **moderate to severe genital psoriasis**. Psoriasis is a skin condition causing red, itchy patches, and this study focuses on the genital area.

To join, you need to be 18 or older, have tried other treatments that didn’t work, and have both genital and non-genital psoriasis. You must also test negative for **TB (tuberculosis)**, a type of lung infection.

However, if you have certain types of psoriasis, recent infections, or other serious health issues, you may not be eligible to participate.

• **Duration:** Participation lasts from screening to a Week 16 check-up.
• **Visits:** Regular doctor visits and tests are required.
• **Risks:** There might be side effects or risks, discussed with your doctor.

Consider these points to decide if this study is right for you. Your doctor can help with more information.